Use of "off-label" and unlicensed drugs in paediatric intensive care unit.

Suppr

超能文献

作者信息

Turner S, Gill A, Nunn T, Hewitt B, Choonara I

出版信息

Lancet. 1996 Feb 24;347(9000):549-50.

PMID:8596300

Abstract

摘要

相似文献

Use of "off-label" and unlicensed drugs in paediatric intensive care unit.

Lancet. 1996 Feb 24;347(9000):549-50.

The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.

Drug Saf. 2004;27(13):1059-67. doi: 10.2165/00002018-200427130-00006.

Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study.

Acta Paediatr. 1999 Sep;88(9):965-8. doi: 10.1080/08035259950168469.

Unlicensed and off-label drug use in children: implications for safety.

Drug Saf. 2002;25(1):1-5. doi: 10.2165/00002018-200225010-00001.

Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety.

Expert Opin Drug Saf. 2006 Sep;5(5):703-18. doi: 10.1517/14740338.5.5.703.

[Off-label and unlicensed drug use: Results from a pilot study in a pediatric intensive care unit].

An Pediatr (Barc). 2017 Jan;86(1):28-36. doi: 10.1016/j.anpedi.2016.01.026. Epub 2016 Apr 14.

Pediatric Off-Label and Unlicensed Drug Use and Its Implications.

Curr Clin Pharmacol. 2017;12(1):18-25. doi: 10.2174/1574884712666170317161935.

Unlicensed and off-label medication use in a general pediatrics ambulatory hospital unit in Israel.

Isr Med Assoc J. 2000 Aug;2(8):595-7.

Off-label and unlicensed drug use among neonatal intensive care units in Southern Italy.

Pediatr Int. 2014 Feb;56(1):57-9. doi: 10.1111/ped.12190.

Off-label and unlicensed prescribing for children: have we made any progress?

Br J Clin Pharmacol. 2007 Jul;64(1):1-2. doi: 10.1111/j.1365-2125.2007.02987.x.

引用本文的文献

Off‑label and unapproved pediatric drug utilization: A meta‑analysis.

Exp Ther Med. 2024 Aug 30;28(5):412. doi: 10.3892/etm.2024.12701. eCollection 2024 Nov.

Adverse drug reactions in paediatric surgery: prospective study on frequency and risk related factors.

BMC Pediatr. 2024 May 18;24(1):344. doi: 10.1186/s12887-024-04803-1.

Prevalence and Nature of Medication Errors and Preventable Adverse Drug Events in Paediatric and Neonatal Intensive Care Settings: A Systematic Review.

Drug Saf. 2019 Dec;42(12):1423-1436. doi: 10.1007/s40264-019-00856-9.

Two decades of off-label prescribing in children: a literature review.

World J Pediatr. 2018 Dec;14(6):528-540. doi: 10.1007/s12519-018-0186-y. Epub 2018 Sep 14.

Medication Repurposing in Pediatric Patients: Teaching Old Drugs New Tricks.

J Pediatr Pharmacol Ther. 2016 Jan-Feb;21(1):36-53. doi: 10.5863/1551-6776-21.1.36.

Patterns of Off-Label Prescribing in the Pediatric Intensive Care Unit and Prioritizing Future Research.

J Pediatr Pharmacol Ther. 2015 May-Jun;20(3):186-96. doi: 10.5863/1551-6776-20.3.186.

It is time to review how unlicensed medicines are used.

Eur J Clin Pharmacol. 2015 Sep;71(9):1029-35. doi: 10.1007/s00228-015-1886-z. Epub 2015 Jul 9.

Off-Label Uses of Omalizumab.

Clin Rev Allergy Immunol. 2016 Feb;50(1):84-96. doi: 10.1007/s12016-015-8490-y.

Clinical setting influences off-label and unlicensed prescribing in a paediatric teaching hospital.

PLoS One. 2015 Mar 10;10(3):e0120630. doi: 10.1371/journal.pone.0120630. eCollection 2015.

Ethics of drug research in the pediatric intensive care unit.

Paediatr Drugs. 2015 Feb;17(1):43-53. doi: 10.1007/s40272-014-0101-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验